Benjamin Cohen, MD
Treatment & Services
- Cancer Screening
- Clinical Trials
- Diagnostic Endoscopy
- Endoscopic Therapy of Anastomotic and Crohn's Disease Strictures
- Esophagogastroduodenoscopy (EGD)
- Gastroenterology
- Ileoscopy
- Polypectomy
- Pouch Center
- Pouchoscopy
Specialty in Diseases & Conditions
- Collagenous Colitis
- Crohn's Disease
- Inflammatory Bowel Disease (IBD)
- Microscopic Colitis
- Ulcerative Colitis
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Benjamin Cohen, MD
Dr. Cohen is a Staff Physician and Co-Section Head and Clinical Director for Inflammatory Bowel Diseases in the Department of Gastroenterology, Hepatology, and Nutrition at the Cleveland Clinic, Cleveland, OH. Throughout his career, Dr. Cohen has merged clinical care with participation in inflammatory bowel disease (IBD) clinical research. His primary research interest has been centered on the safety of biologic medications in the peri-operative period for which he led a large multi-center clinical study. Dr. Cohen has also been a site primary investigator on Phase 3 IBD pharmaceutical clinical trials and collaborative investigator initiated studies. In addition to his research interests, Dr. Cohen also has a strong commitment to IBD education. He is a member of the Crohn’s & Colitis Foundation Professional Education Committee and a co-founder and former chair of Rising Educators Academics and Clinicians Helping IBD (REACH-IBD); a special committee within the Crohn’s & Colitis Foundation of America for trainees and junior faculty to promote collaboration, mentorship, and career advancement. The Crohn’s and Colitis Foundation recognized him for his leadership with the Rising Star award in 2018.Dr. Cohen has also been an active member of the American Gastroenterological Association (AGA) serving on both the Education and Training Committee and Clinical Guidelines Committee.
Dr. Cohen received his MD from the Mount Sinai School of Medicine, where he also completed his internal medicine training. He completed his fellowship in Gastroenterology at the University of California San Diego. During his time at the University of California San Diego, Dr. Cohen also completed a Masters of Advanced Studies in Clinical Research. Dr. Cohen returned to Mount Sinai as the Present-Levison Inflammatory Bowel Disease Fellow from 2011-2012.He remained on faculty at Mount Sinai as the Associate Director of IBD Education and Associate Professor of Medicine until 2020 when he joined the Cleveland Clinic.
Education & Professional Highlights
Appointed
2020
Education & Fellowships
Fellowship - Mount Sinai School of Medicine
Inflammatory Bowel Diseases
New York,
NY
2012
Graduate School - University of California-San Diego
Master of Advanced Studies in Clinical Research
La Jolla,
CA
2011
Fellowship - University of California San Diego Medical Center
Gastroenterology
San Diego,
CA
2011
Residency - Mount Sinai School of Medicine
Internal Medicine
New York,
NY
2008
Internship - Mount Sinai School of Medicine
Internal Medicine
New York,
NY
2006
Medical Education - Mount Sinai School of Medicine
New York,
NY
2005
Undergraduate - University of Pennsylvania
Philadelphia,
PA
1999
Additional Training
- Present-Levison Inflammatory Bowel Disease Fellowship, Icahn School of Medicine at Mount Sinai, 2011-12
Certifications
- Internal Medicine - Gastroenterology
Specialty Interests
Inflammatory Bowel Disease (IBD), Crohn's Disease, Ulcerative Colitis
Awards & Honors
- Crohn's & Colitis Foundation Rising Star Award (2018)
- New York Super Doctors Rising Star (2018-20)
Research & Publications
See publications for Benjamin Cohen, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/25/2025, Dr. Cohen has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Consulting and/or Speaking. Dr. Cohen receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:
- Takeda Pharmaceuticals North America, Inc.
- Med Learning Group
- Johnson & Johnson
- AbbVie, Inc.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
105 Patient Satisfaction Reviews
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.
| Overall | Star Ratings | |
|---|---|---|
| Explains | 4.7 | |
| Courtesy, Respect & Concern | 4.8 | |
| Patient Rating of Doctor | 4.8 |
6 Patient Comments
© 2025 The Cleveland Clinic Foundation. All Rights Reserved. No part of this work may be altered, reproduced, stored in a retrieval system, or transmitted, in any form, by any means, whether electronic, mechanical, by photocopying, recording, or otherwise, without the prior written permission of the Cleveland Clinic.
Reviewed on May 8, 2025
Dr Cohen was very thorough and explained everything to my satisfaction.
Reviewed on Apr 8, 2025
Dr. Gassan Kassim, fellow in IBD working with Dr. Cohen, was outstanding. He was thorough, respectful, and very educational. Spent minimal time with Dr. Cohen but it was sufficient to move forward with additional appointments.
Reviewed on Mar 11, 2025
Outstanding, thorough and comprehensive care. Could not ask for better care. 100% confidence in Dr. Cohen's medical care.
Reviewed on Oct 8, 2024
Lived with Crohns my whole life. Best doctors and team yet!
Reviewed on Aug 6, 2024
Dr. Cohen was not cordial and did not have a good bedside manner. When discussing my symptoms, I felt he belittled them. Makes you feel just like another number.
Reviewed on Jul 16, 2024
I was very pleased with my care by Dr. Cohen and his associate, Dr.Sleiman.